Volume 23, Issue 7, 2023
Meet the Editorial Board Member
Pp: 735-735
Author(s): Ana Conejo-García
DOI: 10.2174/187152062307230209100951
Published on: 09 February, 2023
Advances in the Study of Hexokinase 2 (HK2) Inhibitors
Pp: 736-746
Author(s): Shaopei Wang, Yan Zhuang, Jindan Xu, Yan Tong*, Xiaofei Li* and Chunhong Dong*
DOI: 10.2174/1871520623666221020092423
Published on: 04 November, 2022
Recent Advances in the Chemistry and Biology of Bakuchiol and its Derivatives: An Updated Review
Pp: 747-764
Author(s): Nidhi Gupta*, Payare L. Sangwan, Ravi Shankar and Sumeet Gupta
DOI: 10.2174/1871520622666220812113057
Published on: 13 September, 2022
Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment
Pp: 765-778
Author(s): Asmat Ullah*, Najeeb Ullah, Touseef Nawaz and Tariq Aziz*
DOI: 10.2174/1871520622666220831124321
Published on: 19 September, 2022
Targeting Glutaminolysis to Treat Multiple Myeloma: An In Vitro Evaluation of Glutaminase Inhibitors Telaglenastat and Epigallocatechin-3-gallate
Pp: 779-785
Author(s): Chen Li, Yuhu Feng*, Weiguo Wang, Lingyun Xu, Miao Zhang, Yue Yao, Xiaoqian Wu, Qin Zhang, Wenyue Huang, Xiuxiu Wang, Xue Li, Peipei Ying and Liu Shang
DOI: 10.2174/1871520622666220905142338
Published on: 12 October, 2022
Multitargeting Strategy Using Tetrathiomolybdate and Lenvatinib: Maximizing Antiangiogenesis Activity in a Preclinical Liver Cancer Model
Pp: 786-793
Author(s): Li Nan*, Wan Yuan, Chen Guodong and Huang Yonghui*
DOI: 10.2174/1871520622666220907115027
Published on: 10 October, 2022
Overexpression of Bromodomain and Extraterminal Domain is Associated with Progression, Metastasis and Unfavorable Outcomes: Highlighting Prognostic and Therapeutic Value of the BET Protein Family in Gastric Cancer
Pp: 794-806
Author(s): Shahrzad S. Fard, Shaghayegh Kouchaki, Zahra Salimian, Masoud Sotoudeh, Seyed A. Mousavi, Kamran Alimoghaddam and Seyed H. Ghaffari*
DOI: 10.2174/1871520623666221025145320
Published on: 15 November, 2022
Embelin Enhances the Sensitivity of Renal Cancer Cells to Axitinib by Inhibiting HIF Signaling Pathway
Pp: 807-816
Author(s): Qiong Fang, Zhiying Li, Ye Xue, Xin Zong, Wenshuang Ma, Guangmin Xi, Xiao Feng Zhang and Zuowei Li*
DOI: 10.2174/1871520622666220825155125
Published on: 19 September, 2022
Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine
Pp: 817-831
Author(s): Sonia How Ming Wong, Chee-Mun Fang, Hwei-San Loh and Siew Ching Ngai*
DOI: 10.2174/1871520623666221114095733
Published on: 13 December, 2022
Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells
Pp: 832-838
Author(s): Zhichao Song, Chunhui Wang, Fei Ding, Hao Zou and Chengkui Liu*
DOI: 10.2174/1871520623666221103110934
Published on: 30 November, 2022
Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies
Pp: 839-846
Author(s): Maja Molnar, Melita Lončarić, Teuta Opačak-Bernardi, Ljubica Glavaš-Obrovac and Vesna Rastija*
DOI: 10.2174/1871520623666221027094856
Published on: 15 November, 2022
Network-based Pharmacology and In vitro Validation Reveal that Galangin Induces Apoptosis in Bladder Cancer Cells by Promoting the P53 Signaling Pathway
Pp: 847-857
Author(s): Xiaoming Long, Lin Chen*, Jin Yang*, Taotao Dong, Qisen Cheng, Weiwei Wang, Yujian Zou, Yao Su, Wenbin Dai, Bo Chen and Xin Zhou
DOI: 10.2174/1871520623666221026121600
Published on: 10 November, 2022
